Literature DB >> 1347242

The antinociceptive activity of excitatory amino acids in the rat brainstem: an anatomical and pharmacological analysis.

T S Jensen1, T L Yaksh.   

Abstract

Rats were stereotaxically implanted with microinjection cannulae aimed at sites ranging caudally from the lower medulla and rostrally to the diencephalon and received microinjections of the excitatory amino acid: L-glutamate 30 nmol/0.5 microliters. The subsequent spontaneous behavioral response and the effect on the thermal noxious-evoked tail flick (TF) and hot plate (HP) responses was recorded. From 331 brain sites mapped with glutamate, an elevation of tail flick and hot plate response latencies was observed in 59 cases and in 34 of these sites the antinociceptive activity was preceded by a shortlasting aversion characterized by vocalization and running. The glutamate-sensitive sites at which TF and HP response latencies were elevated were exclusively distributed in the medullary reticular formation (MRF) and the mesencephalic periaqueductal gray matter (PAG). The aversive and antinociceptive activity of glutamate was dose-dependent and mimicked by the excitatory amino acid (EAA) receptor agonists N-methyl-D-aspartate + (NMDA) kainate and less so quisqualate. The EAA receptor antagonists MK-801 and AP-5, but not glutamyl-amino-methyl-sulfonic acid, antagonized in a dose-dependent fashion both the aversive and antinociceptive responses evoked from the PAG. It is suggested that NMDA receptor-linked neurons in the PAG activate both nociceptive and antinociceptive systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347242     DOI: 10.1016/0006-8993(92)90637-o

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Role of angiotensin modulation in primary headaches.

Authors:  Erling Tronvik; Lars Jacob Stovner
Journal:  Curr Pain Headache Rep       Date:  2014-05

Review 2.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

3.  Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.

Authors:  Michael M Morgan; Erin N Bobeck; Susan L Ingram
Journal:  Brain Res       Date:  2009-08-05       Impact factor: 3.252

4.  Involvement of opioid receptors in N-methyl-D-aspartate-induced arterial hypertension in periaqueductal gray matter.

Authors:  S Maione; J Leyva; M Pallotta; L Berrino; V De Novellis; F Rossi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

Review 5.  Glutamate receptor antagonists in the management of migraine.

Authors:  Kayi Chan; Antoinette MaassenVanDenBrink
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

6.  Prolonged noxious stimulation increases periaqueductal gray NMDA mRNA expression: a hybridization study using two different rat models for nociception.

Authors:  W M Renno
Journal:  Ir J Med Sci       Date:  1998 Jul-Sep       Impact factor: 1.568

7.  Transcranial Direct Current Stimulation Alleviates the Chronic Pain of Osteoarthritis by Modulating NMDA Receptors in Midbrain Periaqueductal Gray in Rats.

Authors:  Xinhe Li; Wenwen Zhou; Lin Wang; Yinshuang Ye; Tieshan Li
Journal:  J Pain Res       Date:  2022-01-26       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.